[1]
|
Oskarsson, B., Gendron, T.F. and Staff, N.P. (2018) Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clinic Proceedings, 93, 1617-1628. https://doi.org/10.1016/j.mayocp.2018.04.007
|
[2]
|
Al-Chalabi, A., Hardiman, O., Kiernan, M.C., Chiò, A., Rix-Brooks, B. and van den Berg, L.H. (2016) Amyotrophic Lateral Sclerosis: Moving towards a New Classification System. The Lancet Neurology, 15, 1182-1194. https://doi.org/10.1016/S1474-4422(16)30199-5
|
[3]
|
Ben Hamida, M., Hentati, F. and Ben Hamida, C. (1990) Hereditary Motor System Diseases (Chronic Juvenile Amyotrophic Lateral Sclerosis). Conditions Combining a Bilateral Pyramidal Syndrome with Limb and Bulbar Amyotrophy. Brain, 113, 347-363. https://doi.org/10.1093/brain/113.2.347
|
[4]
|
Luna, J., Diagana, M., Aissa, L., Gouider, R., Henning, F., Basse, A., et al. (2017) Amyotrophic Lateral Sclerosis in Africa: A Multi-Center Cohort Study, ALS and Related Syndromes under the Tropics (TROPALS) Collaboration. 28th International Symposium on ALS/MND, Boston, December 2017, 172.
|
[5]
|
Mehta, P., Kaye, W., Bryan, L., Larson, T., Copeland, T., Wu, J., et al. (2002) Prevalence of Amyotrophic Lateral Sclerosis—United States, 2012-2013. Morbidity and Mortality Weekly Report, 65, 1-12. https://doi.org/10.15585/mmwr.ss6508a1
|
[6]
|
Hultberg, B., Lundblad, A., Masson, P.K. and Ockerman, P.A. (1975) Specificity Studies on α-Mannosidases Using Oligosaccharides from Mannosidosis Urine as Substrates. Biochimica et Biophysica Acta (BBA)—Enzymology, 410, 156-163. https://doi.org/10.1016/0005-2744(75)90216-8
|
[7]
|
Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E.M., Logroscino, G., Robberecht, W., et al. (2017) Amyotrophic Lateral Sclerosis. Nature Reviews Disease Primers, 3, Article No. 17071. https://doi.org/10.1038/nrdp.2017.71
|
[8]
|
DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., et al. (2011) Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron, 72, 245-256. https://doi.org/10.1016/j.neuron.2011.09.011
|
[9]
|
Renton, A.E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J.R., et al. (2011) A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron, 72, 257-268. https://doi.org/10.1016/j.neuron.2011.09.010
|
[10]
|
Chiò, A., Logroscino, G., Traynor, B.J., Collins, J., Simeone, J.C., Goldstein, L.A., et al. (2013) Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature. Neuroepidemiology, 41, 118-130. https://doi.org/10.1159/000351153
|
[11]
|
Schultz, J. (2018) Disease-Modifying Treatment of Amyotrophic Lateral Sclerosis. The American Journal of Managed Care, 24, S327-S335.
|
[12]
|
Guennoc, A.M., Camu, W. and Corcia, P. (2013) The Awaji Criteria: The New Diagnostic Criteria for Amyotrophic Lateral Sclerosis. Revue Neurologique, 169, 470-475. https://doi.org/10.1016/j.neurol.2012.10.007
|
[13]
|
Riva, N., Agosta, F., Lunetta, C., Filippi, M. and Quattrini, A. (2016) Recent Advances in Amyotrophic Lateral Sclerosis. Journal of Neurology, 263, 1241-1254. https://doi.org/10.1007/s00415-016-8091-6
|
[14]
|
Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., et al. (2011) Rate of Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Journal of Neurology, Neurosurgery & Psychiatry, 82, 623-627. https://doi.org/10.1136/jnnp.2010.224501
|
[15]
|
Logroscino, G. and Piccininni, M. (2019) Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference. Neuroepidemiology, 52, 93-103. https://doi.org/10.1159/000493386
|
[16]
|
Chen, K.M. (1995) Disappearance of ALS from Guam: Implications for Exogenous Causes. Rinsho Shinkeigaku, 35, 1549-1553.
|
[17]
|
Pfister, T., Sekhon, R., White, M., Scott, P., Munro, S., Johnston, M., et al. (2013) Familial Amyotrophic Lateral Sclerosis in Alberta, Canada. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14, 273-277. https://doi.org/10.3109/21678421.2012.754044
|
[18]
|
Chiò, A., Borghero, G., Pugliatti, M., Ticca, A., Calvo, A., Moglia, C., et al. (2011) Large Proportion of Amyotrophic Lateral Sclerosis Cases in Sardinia Are Due to a Single Founder Mutation of the TARDBP Gene. Archives of Neurology, 68, 594-598. https://doi.org/10.1001/archneurol.2010.352
|
[19]
|
Steele, J.C. and McGeer, P.L. (2008) The ALS/PDC Syndrome of Guam and the Cycad Hypothesis. Neurology, 70, 1984-1990. https://doi.org/10.1212/01.wnl.0000312571.81091.26
|
[20]
|
Benoit, T. and Corabianu, O. (2015) Evaluation of Stroke Treatment Times in UNV-SI: Retrospective Study on 50 Patients. Revue Neurologique, 171, A31-A32. https://doi.org/10.1016/j.neurol.2015.01.065
|
[21]
|
Wijesekera, L.C. and Nigel Leigh, P. (2009) Amyotrophic Lateral Sclerosis. Orphanet Journal of Rare Diseases, 4, Article No. 3. https://doi.org/10.1186/1750-1172-4-3
|
[22]
|
Marin, B., Fontana, A., Arcuti, S., Copetti, M., Boumédiene, F., Couratier, P., et al. (2018) Age-Specific ALS Incidence: A Dose-Response Meta-Analysis. European Journal of Epidemiology, 33, 621-634. https://doi.org/10.1007/s10654-018-0392-x
|
[23]
|
Logroscino, G., Traynor, B.J., Hardiman, O., Chio, A., Couratier, P., Mitchell, J.D., et al. (2008) Descriptive Epidemiology of Amyotrophic Lateral Sclerosis: New Evidence and Unsolved Issues. Journal of Neurology, Neurosurgery & Psychiatry, 79, 6-11. https://doi.org/10.1136/jnnp.2006.104828
|
[24]
|
Marin, B., Logroscino, G., Boumédiene, F., Labrunie, A., Couratier, P., Babron, M.C., et al. (2016) Clinical and Demographic Factors and Outcome of Amyotrophic Lateral Sclerosis in Relation to Population Ancestral Origin. European Journal of Epidemiology, 31, 229-245. https://doi.org/10.1007/s10654-015-0090-x
|
[25]
|
del Aguila, M.A., Longstreth, W.T., McGuire, V., Koepsell, T.D. and van Belle, G. (2003) Prognosis in Amyotrophic Lateral Sclerosis: A Population-Based Study. Neurology, 60, 813-819. https://doi.org/10.1212/01.WNL.0000049472.47709.3B
|
[26]
|
Mekler, L.B. (1975) On the Problem of Oncogene of Tumor Viruses. Acta Virologica, 19, 501-508.
|
[27]
|
Phukan, J., Pender, N.P. and Hardiman, O. (2007) Cognitive Impairment in Amyotrophic Lateral Sclerosis. The Lancet Neurology, 6, 994-1003. https://doi.org/10.1016/S1474-4422(07)70265-X
|
[28]
|
Fang, F., Bellocco, R., Hernán, M.A. and Ye, W. (2006) Smoking, Snuff Dipping and the Risk of Amyotrophic Lateral Sclerosis—A Prospective Cohort Study. Neuroepidemiology, 27, 217-221. https://doi.org/10.1159/000096956
|
[29]
|
Cozzolino, M., Ferri, A. and Carrì, M.T. (2008) Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications. Antioxidants & Redox Signaling, 10, 405-443. https://doi.org/10.1089/ars.2007.1760
|
[30]
|
Nodera, H., Izumi, Y. and Kaji, R. (2007) [New Diagnostic Criteria of ALS (Awaji Criteria)]. Brain and Nerve, 59, 1023-1029.
|
[31]
|
Costa, J., Swash, M. and de Carvalho, M. (2012) Awaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis: A Systematic Review. Archives of Neurology, 69, 1410-1416. https://doi.org/10.1001/archneurol.2012.254
|
[32]
|
Emberson, J., Lees, K.R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., et al. (2014) Effect of Treatment Delay, Age, and Stroke Severity on the Effects of Intravenous Thrombolysis with Alteplase for Acute Ischaemic Stroke: A Meta-Analysis of Individual Patient Data from Randomized Trials. The Lancet, 384, 1929-1935. https://doi.org/10.1016/S0140-6736(14)60584-5
|
[33]
|
Noto, Y., Misawa, S., Kanai, K., Shibuya, K., Isose, S., Nasu, S., et al. (2012) Awaji ALS Criteria Increase the Diagnostic Sensitivity in Patients with Bulbar Onset. Clinical Neurophysiology, 123, 382-385. https://doi.org/10.1016/j.clinph.2011.05.030
|
[34]
|
Wallace, V.C.J., Ellis, C.M., Burman, R., Knights, C., Shaw, C.E. and Al-Chalabi, A. (2014) The Evaluation of Pain in Amyotrophic Lateral Sclerosis: A Case Controlled Observational Study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15, 520-527. https://doi.org/10.3109/21678421.2014.951944
|
[35]
|
Brooks, B.R., Miller, R.G., Swash, M., Munsat, T.L. and World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1, 293-299. https://doi.org/10.1080/146608200300079536
|
[36]
|
Miller, R.G., Mitchell, J.D., Lyon, M. and Moore, D.H. (2002) Riluzole for Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease (MND). Cochrane Database of Systematic Reviews, 2, CD001447. https://doi.org/10.1002/14651858.CD001447
|
[37]
|
Elamin, M., Bede, P., Montuschi, A., Pender, N., Chio, A. and Hardiman, O. (2015) Predicting Prognosis in Amyotrophic Lateral Sclerosis: A Simple Algorithm. Journal of Neurology, 262, 1447-1454. https://doi.org/10.1007/s00415-015-7731-6
|
[38]
|
Paganoni, S., Macklin, E.A., Karam, C., Yu, H., Gonterman, F., Fetterman, K.A., et al. (2017) Vitamin D Levels Are Associated with Gross Motor Function in Amyotrophic Lateral Sclerosis. Muscle & Nerve, 56, 726-731. https://doi.org/10.1002/mus.25555
|